Milroy WF. An undescribed variety of hereditary edema. N Y Med J. 1892;56:505-8.

Tille JC, Pepper MS. Hereditary vascular anomalies: new insights into their pathogenesis. Arterioscler Thromb Vasc Biol. 2004;24:1578-90.

Sabin F. On the origin of the lymphatic system from the veins and the development of the lymph hearts and thoracic duct in the pig. Am J Anat. 1902;1:367-91.

Huntington GS, McClure CF. The anatomy and development of the jugular lymph sac in the domestic cat (Felis domestica). Am J Anat. 1910;10:177-311.

Wigle JT, Oliver G. Prox1 function is required for the development of the murine lymphatic system. Cell. 1999;98:769-78.

Schneider M, Othman-Hassan K, Christ B, Wilting J. Lymphangioblasts in the avian wing bud. Dev Dyn. 1999;216:311-9.

Ferrara N, Alitalo K. Clinical applications of angiogenic growth factors and their inhibitors. Nat Med. 1999;5:1359-64.

Dumont DJ, Jussila L, Taipale JL. Cardiovascular failure in mouse embryos deficient in VEGF receptor-3. Science. 1998;282:946-9.

Jussila L, Alitalo K. Vascular growth factors and lymphangiogenesis. Physiol Rev. 2002;82:673-700.

Kaipainen A, Korhonen J, Mustonen T. Expression of the fms-like tyrosine kinase FLT4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci. USA. 1995;92:3566-70.

Petrova TV, Makinen T, Alitalo K. Signaling via vascular endothelial growth factor receptors. Exp Cell Res. 1999;253:117-30.

Karkkainen M, Saaristo A, Jussila L. A model for gene therapy of human hereditary lymphedema. Proc Natl Acad Sci. USA. 2001;98:12677-82.

On Line Mendelian Inheritance in Man. .

Witte MH, Way DL, Witte CL, Bernas M. Lymphangiogenesis: mechanisms, significance and clinical implications. Regulation of angiogenesis. 1997:65-112.

Morgan T. Turner syndrome: diagnosis and management. Am Fam Physician. 2007;76:405-10.

Chevernak FA, Issacson G, Blakemore KJ. Fetal cystic hygrome: Cause and natural history. N Engl J Med. 1983;309:822-5.

Boucher CA, Sargent CA, Ogata T, Affara NA. Breakpoint analysis of Turner patients with partial Xp deletions: implications for the lymphoedema gene location. J Med Genet. 2001;38:591-8.

Witte MH, Erickson R, Reiser FA, Witte CL. Genetic alterations in lymphedema. Phlebolymphology. 1997;16:19-25.

Witte MH, Erickson R, Bernas M. Phenotypic and genotypic heterogeneity in familial Milroy lymphedema. Lymphology. 1998;31:145-55.

Ferrell RE, Levinson KL, Esman JH. Hereditary lymphoedema: evidence for linkage and genetic heterogeneity. Hum Mol Genet. 1998;7:2073-8.

Holberg CJ, Erickson RP, Bernas MJ. Segregation analyses and a genome-wide linkage search confirm genetic heterogeneity and suggest oligogenic inheritance in some Milroy congenital primary lymphedema families. Am J Med Genet. 2001;98:303-12.

Karkkainen MJ, Ferrell RE, Lawrence EC. Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema. Nat Genet. 2000;25:153-9.

Karkkainen MJ, Saaristo A, Jussila L. A model for gene therapy of human hereditary lymphedema. Proc Natl Acad Sci U S A. 2001;98:12677-82.

Fink AM, Kaltenegger I, Schneider B, Frühauf J, Jurecka W, Steiner A. Serum level of VEGF-D in patients with primary lymphedema. Lymphology. 2004;37:185-9.

Meige H. Dystrophie oedemateuse héreditaire. Presse Med. 1898;6:341-3.

Burnand KG, Mortimer PS. Lymphangiogenesis and genetics of lymphoedema. Diseases of the lymphatics. 2003:102-9.

Northrup KA, Witte MH, Witte CL. Syndromic classification of hereditary lymphedema. Lymphology. 2003;36:162-89.

Browse NL, Stewart G. Lymphoedema: pathophysiology and classification. J Cardiovasc Surg (Torino). 1985;26:91-106.

Rosbotham JL, Brice GW, Child AH, Nunan TO, Mortimer PS, Burnand KG. Distichiasis-lymphoedema: clinical features, venous function and lymphoscintigraphy. Br J Dermatol. 2000;142.

Mangion J, Rahman N, Mansour S. gene for lymphedema-distichiasis maps to 16q24.3. Am J Hum Genet. 1999;65:427-32.

Kriederman BM, Myloyde TL, Witte MH. FOXC2 haploinsufficient mice are a model for human autosomal dominant lymphedema-distichiasis syndrome. Hum Mol Genet. 2003;12:1179-85.

Iida K, Koseki H, Kakinuma H. Essential roles of the winged helix transcription factor MFH-1 in aortic arch patterning and skeletogenesis. Development. 1997;124:4627-38.

Finegold DN, Kimak MA, Lawrence EC. Truncating mutations in FOXC2 cause multiple lymphedema syndromes. Hum Mol Genet. 2001;10:1185-9.

Glade C, van Steensel MA, Steijlen PM. Hypotrichosis, lymphedema of the legs and acral telangiectasias-new syndrome?. Eur J Dermatol. 2001;11:515-7.

Irrthum A, Devriendt K, Chitayat D. Mutations in the transcription factor gene SOX18 underlie recessive and dominant forms of hypotrichosis-lymphedema-telangiectasia. Am J Hum Genet. 2003;72:1470-8.

Aagenaes O, van der Hagen CB, Refsum S. Hereditary recurrent intrahepatic cholestasis from birth. Arch Dis Child. 1968;43:646-57.

Bull LN, Roche E, Song EJ. Mapping of the locus for cholestasis-lymphedema syndrome (Aagenaes syndrome) to a 6.6-cM interval on chromosome 15q. Am J Hum Genet. 2000;67:994-9.

Witte MH, Ohkuma M, Andrade M, Campisi C, Boccardo F. Nature's historic gap: the 20th century of lymphology. Lymphology. 2005;38:157-8.